Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00957827 · ClinicalTrials.gov registry record · NA

Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip

A NA study, sponsored by University of Pennsylvania.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT00957827: Clinical Trial NA study, sponsored by University of Pennsylvania.

NCT00957827 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00957827, a NA study, was terminated before completion, sponsored by University of Pennsylvania.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Facial lacerations are a commonly encountered problem in the emergency department. Despite this, few original articles have been written concerning the management of lacerations of the lip which communicate with the oral cavity. Specifically, no study has been able to definitively show whether the use of antibiotics for these wounds decreases the infection rate. These cutaneous wounds are a unique type of laceration because they are continuously contaminated with oropharyngeal flora. Contaminated wounds result in larger, less cosmetic scars. Scars which involve the face have been shown to have a negative psychological impact. In this study, the investigators aim to determine whether the use of antibiotics decrease the rate of infection in lacerations of the lip which communicate with the oral cavity. Patients will be randomized to one of two currently practiced therapies. Patients will receive either cephalexin or no treatment following the repair of their through-and-through lip lacerations to determine whether antibiotics decrease the infection rate in these wounds.

Primary Outcome

Presence or absence of infection

Interventions

  • DRUG placebo
  • DRUG keflex

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2009-08
Est. Completion 2011-08
Phase NA
University of Pennsylvania

1,423 total trials

Why NCT00957827 stopped before completion

NCT00957827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT00957827 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00957827 about?

NCT00957827 is a clinical study titled "Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip". Facial lacerations are a commonly encountered problem in the emergency department. Despite this, few original articles have been written concerning the management of lacerations of the lip which communicate with the oral cavity. Specifically, no study has been able to definitively show whether the u...

What is the current status of trial NCT00957827?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2009-08. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00957827?

The interventions under investigation include: placebo (DRUG), keflex (DRUG).

Who is sponsoring clinical trial NCT00957827?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00957827's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00957827, the US trial registry maintained by the National Library of Medicine. NCT00957827 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.